Characteristics | PICU mortality | P-Value | In-hospital mortality | P-Value | Missing data | Number of Missing | |||
---|---|---|---|---|---|---|---|---|---|
Non-survive NÂ =Â 304 | Survive NÂ =Â 2142 | Non-Survive NÂ =Â 395 | Survive NÂ =Â 2051 | (NÂ =Â 338) | |||||
Demographics | |||||||||
 Age (Month) | 5.9(0.67–49.4) | 4(0.67–22) | 0.013 a | 6.4(0.9–51) | 3.93(0.63–21.17) | < 0.001 a | 3.6 (0.27–18.5) | 0 | |
 Neonate (< 1 month) | 82(27.0%) | 604(28.2%) | 0.023 c | 101(14.8%) | 585(85.2%) | < 0.001 c | 100(29.6%) | 0 | |
 Infant (1–12 month) | 94(30.9%) | 824(38.3%) | 125(13.7%) | 790(86.3%) | 136(40.2%) | 0 | |||
 Child (12–144 month) | 117(38.5%) | 675(31.5%) | 150(19%) | 642(81%) | 98(29%) | 0 | |||
 Adolescent (> 144 month) | 11(3.6%) | 42(2.0%) | 19(4.8%) | 34(1.7%) | 4(1.2%) | 0 | |||
 Male | 161(53.0%) | 1218(56.9%) | 0.20 c | 209(9%) | 1170(47%) | 0.13 c | 197(58.3) | 0 | |
 Female | 143(47.0%) | 924(43.1%) | 186(7.4%) | 881(36.6%) | 141(41.7) | 0 | |||
Vital signs | |||||||||
 Temperature(°C) | 37(36.5–37.5) | 37(36–37) | 0.015 a | 37(36–37.5) | 37(36.8–37.4) | 0.14 a | 37(36–37.4) | 60 | |
 Diastolic (mmHg) | 56(40–70) | 55(44–68) | 0.682 a | 56(40–69) | 55(44–68) | 0.561 a | 55(43–69) | 42 | |
 Systolic (mmHg) | 95(73.2–111.8) | 97(81–110) | 0.038 a | 95(75–111) | 97(81–110) | < 0.001 a | 98(79–109) | 42 | |
 Fio2(mmHg) | 40(29–90) | 21(21–40) | < 0.001 a | 40(29–80) | 21(21–40) | < 0.001 a | 21(21–40) | 0 | |
 RR (breaths/min) | 38(28–44) | 38(28–44) | 0.114 a | 35(25–45) | 37(28–44) | 0.274 a | 35(25–42) | 35 | |
 Pupillary response | Normal | 232(76.3%) | 2075(96.9%) | < 0.001b | 1996(81.6%) | 311(12.7%) | < 0.001b | 321(95.5%) | 0 |
Abnormal | 72(23.7%) | 67(3.1%) | 55(2.3%) | 84(3.4%) | 15(4.5%) | 0 | |||
Lab result tests | |||||||||
 Glucose (mg/dL) | 124.5(92–178) | 110(87–143) | < 0.001 a | 122(90–170) | 110(87–143) | 0.001 a | 93(71–129.7) | 0 | |
 Urea (mg/dL) | 32.8(19–51) | 21(14–33) | < 0.001 a | 30(18–48) | 21(14–33) | < 0.001 a | 20(14–30) | 0 | |
 Cr (mg/dL) | 0.90(0.5–1) | 0.5(0.5–0.7) | < 0.001 a | 0.85(0.5–0.9) | 0.78(0.5–0.7) | < 0.001 a | 0.58(0.5–0.71) | 0 | |
 K (mEq/L) | 4.3(3.5–4.9) | 4.4(3.9–4.8) | 0.022 a | 4.3(3.5–4.9) | 4.4(3.9–4.8) | 0.003 a | 4.22(3.7–4.7) | 48 | |
 GCS | 12(7–15) | 15(13–15) | < 0.001 a | 12(7–15) | 15(13–15) | < 0.001 a | 15(13–15) | 71 | |
 Plate let (103 cells/mm3) | 155(56.5–273) | 296(202–419) | < 0.001 a | 159(56–278) | 300(207–421) | < 0.001 a | 291(183–432) | 89 | |
 PT | 14.5(12.6–20.7) | 13(12–14) | < 0.001 a | 14(12.5–19.4) | 13(12–14) | < 0.001 a | 13(12–14) | 97 | |
 PTT | 36(30–48) | 32(29–36) | < 0.001 a | 35(30–45) | 32(29–36) | < 0.001 a | 32(30–37) | 65 | |
 HR (beats/min) | 139(118–156.7) | 136(120–153) | 0.455 a | 138(119–156) | 136(120–153) | 0.427 a | 133(120–151) | 42 | |
 WBC (103 cells/mm3) | 11.7(6.4–17.3) | 8.3(11.6–16.1) | 0.394 a | 11.4(6.1–17.0) | 11.7 (8.4–16.1) | 0.041 a | 11(8.5–15.8) | 89 | |
 PCO2(mmHg) | 32(26.5–39.7) | 32.4(26.6–39) | 0.480 a | 35(27–42) | 32(26–38) | 0.775 a | 36.9(30.1–43.4) | 18 | |
 PH | 7.34(7.24–7.41) | 7.37(7.30–7.41) | < 0.001 a | 7.34(7.26–7.41) | 7.37(7.30–7.41) | < 0.001 a | 7.34(7.29–7.39) | 18 | |
 TCO2(mEq/L) | 20.4(16.1–23.6) | 21(18–236) | 0.06 a | 21(16.5–24.2) | 21(18–23.5) | 0.384 a | 21.34(19–24.3) | 18 | |
 PaO2(mmHg) | 94(92–99) | 95.9(95–99) | 0.004 a | 93.93(92–99) | 96.04(94–100) | < 0.001 a | 97(95–99) | 18 | |
 Readmission | 79(26%) | 523(24.4%) | 0.298 b | 105(26.6%) | 497(24.2%) | 0.176 b | 138(40.8%) | 0 | |
Type admission | |||||||||
 Emergency | 108(35.3%) | 618(28.9%) | 0.008 c | 584(25%) | 142(5%) | 0.001 c | 133(39.3%) | 0 | |
 Referral | 142(46.7%) | 1035(48.3%) | 995(41%) | 182(7%) | 171(50.6%) | 0 | |||
 Elective | 54(17.8%) | 489(22.8%) | 472(20%) | 71(2%) | 34(10.1%) | 0 | |||
Type of diagnosis based on PIM-3 | |||||||||
 Very High Risk | 104(34.2%) | 98(4.5%) | < 0.001 c | 127(32.2%) | 75(3.7%) | < 0.001 c | 11(3.3%) | 0 | |
 High Risk | 42(13.8%) | 46(2.1%) | 53(13.4%) | 35(1.7%) | 3(0.9%) | 0 | |||
 Low Risk | 36(11.8%) | 174(8.1%) | 51(12.9%) | 159(7.8%) | 5(1.5%) | 0 | |||
 Mechanical ventilation | 70(23%) | 159(7.45%) | < 0.001 b | 89(3.7%) | 140(5.7%) | < 0.001b | 39(11.5%) | 0 | |
 PRISM-3 score | 12(8,19) | 5(2,8.2) | < 0.001 a | 11(7,19) | 5(2,8) | < 0.001 a | 5(2–9) | 0 | |
 PIM-3 score | 4(2,9) | 2.(2,3) | < 0.001 a | 4(2,8) | 2.(2,3) | < 0.001 a | 2(2–4) | 0 | |
 LOS in Hospital (day) | 11(5–23.7) | 8(4–15) | < 0.001 a | 12(5–26) | 8(4–15) | < 0.001 a | 9(4–17) | 0 | |
 LOS in ICU (day) | 8(3–18.5) | 7(3.7–13) | < 0.029 a | 8(3–19) | 7(4–12) | 0.004 a | 7(4–14) | 0 | |
Type of diagnosis based on the ICD-10 | |||||||||
 Congenital malformation | 62(20.4%) | 539(25.2%) | 0.365 c | 88(22.3%) | 513(85.3%) | 0.266 c | 114(33.7%) | 0 | |
 Diseases of the digestive system | 43(14.1%) | 296(13.8%) | 54(13.7%) | 285(84.0%) | 63(18.6%) | 0 | |||
 Diseases of the respiratory system | 42(13.8%) | 224(10.5%) | 51(12.9%) | 215(80.8%) | 31(9.2) % | 0 | |||
 Neoplasms, Diseases of the blood | 34(11.2%) | 167(7.8%) | 43(10.9%) | 158(78.6%) | 17(5.1%) | 0 | |||
 Diseases of genitourinary system | 15(4.9%) | 94(4.4%) | 23(5.82%) | 86(78.8%) | 11 (3.3%) | 0 | |||
 Infectious diseases | 15(4.9%) | 115(5.4%) | 22(5.6%) | 108(83%) | 8 (2.4%) | 0 | |||
 Metabolic diseases | 15(4.9%) | 102(4.8%) | 18(4.6%) | 99(84.6%) | 12 (3.6%) | 0 | |||
 Diseases of the circulatory system | 10(3.3%) | 73(3.4%) | 14(3.5%) | 69(83.1%) | 10 (3%) | 0 | |||
 Diseases of the nervous system | 8(2.6%) | 55(2.6%) | 8(2%) | 55(87.3%) | 7(2.1%) | 0 | |||
 Certain conditions originating in the perinatal period | 6(2%) | 61(2.8%) | 7(1.8%) | 60(89.6%) | 15(4.4%) | 0 | |||
 Other disease | 54(17.8%) | 416(19.3%) | 67(16.9%) | 403(85.8%) | 50(14.7%) | 0 |